A detailed history of Sherbrooke Park Advisers LLC transactions in Incyte Corp stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 7,000 shares of INCY stock, worth $611,170. This represents 0.21% of its overall portfolio holdings.

Number of Shares
7,000
Previous 6,195 12.99%
Holding current value
$611,170
Previous $375 Million 27.08%
% of portfolio
0.21%
Previous 0.17%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$55.17 - $71.22 $44,411 - $57,332
805 Added 12.99%
7,000 $477 Million
Q1 2025

May 15, 2025

BUY
$60.0 - $75.26 $371,700 - $466,235
6,195 New
6,195 $375 Million
Q2 2024

Aug 14, 2024

BUY
$51.18 - $63.75 $438,663 - $546,401
8,571 Added 53.12%
24,707 $1.5 Billion
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $618,430 - $728,228
10,936 Added 210.31%
16,136 $919 Million
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $1.41 Million - $1.73 Million
-27,023 Reduced 83.86%
5,200 $327 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $1.16 Million - $1.33 Million
20,123 Added 166.31%
32,223 $1.86 Billion
Q2 2023

Aug 14, 2023

BUY
$60.95 - $75.51 $195,040 - $241,632
3,200 Added 35.96%
12,100 $753 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $625,047 - $765,489
8,900 New
8,900 $643 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $19.4B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.